Active substance | Cabergolina |
---|---|
Water Retention | No |
Hepatotoxicity | Low risk, but liver function tests are recommended |
Lab Test | Prolactin levels, liver function tests |
Also known as | Cabaser |
Blood pressure | May cause hypotension |
Trade name | Dostinex |
Storage conditions | Store at room temperature, protect from light and moisture |
Chemical name | Cabergoline |
Formula | C26H37N5O2 |
Substance class | Ergoline derivative, Dopamine D2 receptor agonist |
Main action | Inhibition of prolactin secretion |
Half-life | 63 to 69 hours |
Dosage (medical) | Typically 0.5 mg per week, may vary based on condition |
Dosage (sports) | Not specified or recommended for sports use |
Effects | Reduces prolactin levels, may help treat symptoms associated with hyperprolactinemia |
Side effects | Nausea, headache, dizziness, orthostatic hypotension |
Use in sports | Not officially sanctioned, possibly used to control side effects of anabolic steroids |
Active ingredient, mg | 0,5 |
Release form | Pack (8 Pills) |
1 Pill, mg | 0,5 |
Manufacturer | Pfizer Labs |
Packing | 1 pill, Packing (8 Pills) |
Cabergoline, Dostinex, Post cycle therapy
Reviews
There are no reviews yet.